Anagram Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Anagram Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Assess the Safety and Efficacy of ANG003 (NCT07450547) | Anagram Therapeutics, Inc. | 2026-04-24 |
| Phase 1 Study to Assess Safety and Efficacy of ANG003 (NCT06052293) | Anagram Therapeutics, Inc. | 2023-08-25 |
Track Anagram Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.